Alterity Therapeutics Ltd (NASDAQ:ATHE) Q2 2021 Earnings Conference Call February 25, 2021 5:00 PM ET Company Participants David Stamler - CEO, Chief Medical Officer & SVP, Clinical Development Kathryn Andrews - CFO Conference Call Participants Operator Good morning, and welcome to the Alterity Therapeutics H1 Financial Results and Business update. [Operator Instructions]. Today's call is being recorded. And I'd like to introduce you to our host, Dr. David Stamler, Alterity Therapeutics Chief Executive Offi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Title of each class Trading Symbol Name of each exchange on which registered American Depositary Shares, each representing sixty Ordinary Shares ATHE NASDAQ Capital Market FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Title of each class Trading Symbol Name of each exchange on which registered American Depositary Shares, each representing sixty Ordinary Shares ATHE NASDAQ Capital Market FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT ...